Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_16-cv-06830/USCOURTS-cand-3_16-cv-06830-0/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

NEVRO CORP,

Plaintiff,

v.

BOSTON SCIENTIFIC CORPORATION, 

et al.,

Defendants.

Case No. 16-cv-06830-VC 

ORDER ON SEALING MOTIONS

Re: Dkt. Nos. 24, 29

Boston Scientific's presentation in support of its motion to seal portions of the motion to 

dismiss and discovery letter is inadequate. Boston Scientific speaks in abstract terms about how 

disclosure of the information will cause competitive harm but provides no specific reasons why 

this will be so. Indeed, companies often disclose the type of information that Boston Scientific 

seeks to conceal from the public here. Accordingly, these motions are denied without prejudice. 

Boston Scientific will be given one more chance, at the upcoming case management conference, 

to make a much stronger and more specific showing that it will suffer competitive harm from 

disclosure of this information. Assuming Boston Scientific can't make that showing, the 

redacted portions of the discovery letter will be unsealed and the motion to dismiss will not be 

considered by the court unless submitted publicly without redactions. See Civil L.R. 79-5(e)-(f).

IT IS SO ORDERED.

Dated: December 28, 2016

______________________________________

VINCE CHHABRIA

United States District Judge

Case 3:16-cv-06830-VC Document 34 Filed 12/28/16 Page 1 of 1